Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
RCD405:New treatment paradigm for patients with COPD
| Reference number | 2022-03487 |
| Coordinator | Arcede Pharma AB |
| Funding from Vinnova | SEK 1 698 150 |
| Project duration | April 2023 - December 2024 |
| Status | Ongoing |
| Venture | Swelife and Medtech4Health - Collaborative Projects for Improved Health |
| Call | Swelife and Medtech4Health - Collaborative projects for better health autumn 2022 |
Last updated 5 December 2024
Reference number 2022-03487
